NewAmsterdam Pharma raises $196m through Series A funding round
Clinical stage company NewAmsterdam Pharma (NAP) has raised $196m (€160m) through Series A funding round...
Clinical stage company NewAmsterdam Pharma (NAP) has raised $196m (€160m) through Series A funding round...
AM-Pharma has announced the enrolment of first participants in an exploratory cohort in Phase III...
KU Leuven in Belgium has partnered with contract development and manufacturing organisation, Batavia Biosciences, to...
Equflow develops and produces disposable and single-use flowmeters, as well as all required components, for...
Lead Pharma has signed a collaboration and license agreement with Roche for the development of...
Scenic Biotech has entered into a multi-year strategic partnership with Roche unit Genentech in a...
Intravacc has partnered with contract development and manufacturing organisation (CDMO) Celonic Group for the design,...
Sanofi has formed a multi-programme collaboration with biotechnology firm Kymera Therapeutics to develop and commercialise...
Dutch research and development vaccine institute Intravacc has collaborated with cancer immunotherapies developer CimCure to...
Dutch research and development vaccine institute Intravacc has collaborated with Wageningen Bioveterinary Research (WBVR) and...